Michael Mühlegger

Michael Mühlegger

Head of Marketing Communications

Michael Mühlegger is the Head of Marketing Communications at Single Use Support. He has 10+ years experience in the fields of marketing, inside sales, communications, content management, and creative production. With a keen understanding of market dynamics and customer behavior, Michael has successfully implemented innovative marketing strategies to drive business growth and enhance brand visibility.

He has a strong background in content management, with a focus on life sciences and biopharma trends, and is adept at creating compelling content across multiple platforms to engage audiences and effectively communicate brand messages.

Articles written by Michael Mühlegger

Tim Robinson Appointed Chair of the Board at Single Use Support

Tim Robinson Appointed Chair of the Board at Single Use Support

Single Use Support welcomes Tim Robinson as its new Chairman of the Board. His appointment marks another significant step in strengthening the company’s leadership and strategic direction as it continues to scale in the biopharma industry. Kufstei...

Michael Mühlegger
Michael Mühlegger
Blog
Ania W. Payne, PhD Appointed New Chief Strategy and Marketing Officer of Single Use Support

Ania W. Payne, PhD Appointed New Chief Strategy and Marketing Officer of Single Use Support

Single Use Support Announces Ania Payne as new Chief Strategy and Marketing Officer further Strengthening the Leadership Team Single Use Support is pleased to announce the appointment of Ania W. Payne, PhD as Chief Strategy and Marketing office...

Michael Mühlegger
Michael Mühlegger
Blog
Darren Verlenden new CEO of Single Use Support

Darren Verlenden new CEO of Single Use Support

Single Use Support Announces Darren Verlenden as CEO and Strengthens Leadership Team for Further Growth and Global Expansion. Single Use Support, a leading provider of innovative fluid management and cold chain solutions for the biopharmaceutic...

Michael Mühlegger
Michael Mühlegger
Blog
Novo Holdings Acquires Majority Stake in Single Use Support

Novo Holdings Acquires Majority Stake in Single Use Support

The Danish company Novo Holdings has acquired a 60% majority stake in the Austrian-based company Single Use Support, thereby strengthening the company's further growth on a global level. KUFSTEIN, 15 May 2024 - Founded seven years ago by Johanne...

Blog
Sustainability Report: Commitment to Protecting Life and the Environment

Sustainability Report: Commitment to Protecting Life and the Environment

Sustainability in Biopharmaceutical Fluid & Cold Chain Management As the biopharmaceutical industry faces unprecedented challenges and opportunities, Single Use Support is committed to advancing our mission of developing and delivering inno...

Michael Mühlegger
Michael Mühlegger
Blog
Innovations for the biopharmaceutical industry made in Tyrol

Innovations for the biopharmaceutical industry made in Tyrol

Siemens supports the expansion course of the global player Single Use Support What started with a vision has rapidly developed into a globally active technology company. Single Use Support specializes in the development and production of mechat...

Michael Mühlegger
Michael Mühlegger
Blog
Grand opening of Single Use Support’s second location

Grand opening of Single Use Support’s second location

With the official inauguration of its second site in Hall in Tyrol, the Austrian biopharma fluid management specialist is increasing its capacities of office spaces, warehouse and production of single-use systems threefold.  Single Use Support ...

Michael Mühlegger
Michael Mühlegger
Blog
Explosive Growth Rate: Single Use Support achieves more than EUR 130 million revenue in 2021

Explosive Growth Rate: Single Use Support achieves more than EUR 130 million revenue in 2021

The Austrian Biopharma fluid management specialist continues its revenue upwards trend with a strong and growing team of close to 150 employees. Since its foundation by Johannes Kirchmair und Thomas Wurm in 2016, the Austrian-based company coul...

Michael Mühlegger
Michael Mühlegger
Blog
mRNA vaccines: How to safely ship and store them

mRNA vaccines: How to safely ship and store them

In the past few years, awareness of the mRNA vaccine supply chain has increased considerably, both in the pharma industry and among the wider public. These vaccines, including lipid nanoparticles and other components, require the highest level of ...

Michael Mühlegger
Michael Mühlegger
Blog
CDMO in Biopharma: Opportunity or risk?

CDMO in Biopharma: Opportunity or risk?

In this article, we will discuss the differences between CMOs (contract manufacturing companies) and CDMOs (contract development and manufacturing companies), the characteristics and types of them, the services that they typically offer, the oppor...

Michael Mühlegger
Michael Mühlegger
Blog
Annex 1: All you need to know

Annex 1: All you need to know

GMP Annex 1, the European guideline for “Manufacture of sterile medicinal products”, has been updated in 2023. The revision’s changes have added several challenges, but also chances for manufacturers in order to comply with the new regulations....

Michael Mühlegger
Michael Mühlegger
Blog
Oligonucleotide manufacturing – challenges & solutions

Oligonucleotide manufacturing – challenges & solutions

Oligos - what are they? Oligonucleotides (also referred to as oligos) are short nucleic acid sequences, made up of a strand of nucleic acid, either DNA or RNA. They represent an increasingly important growth area for the biopharmaceutical manufact...

Michael Mühlegger
Michael Mühlegger
Blog
Oligonucleotides simply explained

Oligonucleotides simply explained

What are oligonucleotides? Oligonucleotides (also referred to as oligos) are short nucleic acid polymers, made up of a strand of DNA or RNA. They are synthetically made and used for a variety of research, diagnostics, and therapeutic applicatio...

Michael Mühlegger
Michael Mühlegger
Blog
Sustainable Practices: The Green in Single Use Support

Sustainable Practices: The Green in Single Use Support

Environmental impact from headquarters and beyond Single Use Support is committed to sustainability and environmental responsibility in our business operations. We believe that our innovative single-use technologies can contribute to the reduct...

Michael Mühlegger
Michael Mühlegger
Blog
The Role of Single-Use Systems in Cell and Gene Therapies

The Role of Single-Use Systems in Cell and Gene Therapies

As cell and gene therapies (CGT) continue to advance, single-use systems have become essential for maintaining the safety and effectiveness of these intricate biological products. These systems not only improve sterility but also simplify manufact...

Blog
FDA approved Antibody Drug Conjugates (ADCs)

FDA approved Antibody Drug Conjugates (ADCs)

The number of FDA approved antibody-drug conjugates has rapidly risen in the last decade and promises to continue to do so. ADCs are very effective drugs used in the treatment of metastatic diseases and anticancer therapy. Many cancer patients cou...

Blog
ADC manufacturing: Process, Challenges & Solutions

ADC manufacturing: Process, Challenges & Solutions

Antibody drug conjugates (ADCs) are a promising alternative for cancer therapy. Due to the targeting quality of the monoclonal antibody (mAb) in combination with a highly toxic payload drug, it becomes easier to target cancer cells without potenti...

Blog